A study demonstrated that the initiation of CGMS before subcutaneous insulin infusion increases the CGMS frequency use in type 1 diabetes mellitus patients and significantly reduces the time spent in hypoglycemia [89]. Here, INS is linked to type 1 diabetes mellitus.